Edition:
United States

Cynosure Inc (CYNO.OQ)

CYNO.OQ on NASDAQ Stock Exchange Global Select Market

66.30USD
24 Feb 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$66.30
Open
--
Day's High
--
Day's Low
--
Volume
500
Avg. Vol
229,534
52-wk High
$66.65
52-wk Low
$37.82

CYNO.OQ

Chart for CYNO.OQ

About

Cynosure Inc. (Cynosure) develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce... (more)

Overall

Beta: 1.64
Market Cap(Mil.): $1,581.81
Shares Outstanding(Mil.): 23.86
Dividend: --
Yield (%): --

Financials

  CYNO.OQ Industry Sector
P/E (TTM): 101.93 51.59 29.63
EPS (TTM): 0.65 -- --
ROI: 3.38 7.69 12.96
ROE: 3.58 11.60 14.11

BRIEF-Cynosure agrees to termination fee of $57.7 mln for Hologic deal

* Hologic - upon termination of deal under specified circumstances Cynosure has agreed to pay co termination fee of about $57.7 million Source text - http://bit.ly/2kuOElN Further company coverage:

Feb 14 2017

Hologic to buy Cynosure to expand into medical aesthetics

Hologic Inc said on Tuesday it would acquire medical aesthetics company Cynosure Inc for $1.65 billion as it looks to capitalize on an increase in medical procedures that are not traditionally reimbursed.

Feb 14 2017

UPDATE 3-Hologic to buy Cynosure to expand into medical aesthetics

* Cynosure shares up 28 pct; Hologic down 3.6 pct (Adds analyst comments, details)

Feb 14 2017

BRIEF-Hologic to acquire Cynosure for $1.65 bln

* Hologic to acquire Cynosure, leader in medical aesthetics systems and technologies, in all-cash tender offer that combines two complementary businesses

Feb 14 2017

Hologic to buy Cynosure for $1.65 bln

Feb 14 Hologic Inc said on Tuesday that it would acquire medical aesthetics company Cynosure Inc for $1.65 billion.

Feb 14 2017

BRIEF-Cynosure Q4 non-GAAP EPS $0.44

* Cynosure achieves record quarterly revenue of $122.1 million in the fourth quarter of 2016, up 19 percent year-over-year

Feb 07 2017

BRIEF-Cynosure says entered into agreement to settle complaint filed by Arcare

* Cynosure Inc says on January 26, 2017, entered into an agreement to settle complaint filed by Arcare, Inc

Jan 27 2017

BRIEF-Cynosure receives CFDA nod to market the Icon aesthetic system in China

* Cynosure receives CFDA clearance to market the Icon aesthetic system in China

Nov 29 2016

BRIEF-Cynosure promotes Doug Delaney to CCO

* Cynosure promotes Doug Delaney to chief commercial officer Source text for Eikon: Further company coverage:

Nov 01 2016

BRIEF-Cynosure posts Q3 non-gaap EPS of $0.29

* Cynosure announces record third-quarter revenues; revenues increase 36 percent from prior year to $106.4 million

Oct 25 2016

More From Around the Web

Competitors

Earnings vs. Estimates